Oliver-mcfarlane Syndrome; Omcs

Table of contents:

Description
Related genes
Clinical Features
Incidence and onset information
Alternative Names
Researches and researchers
Gene Panels
Sources and references

Description

Oliver-McFarlane syndrome is a rare congenital disorder characterized by trichomegaly, severe chorioretinal atrophy and multiple pituitary hormone deficiencies, including growth hormone (GH ), gonadotropins (see {118860}), and thyroid-stimulating hormone (TSH; see {118850}). Thyroid and GH abnormalities may be present at birth and, if untreated, result in intellectual impairment and profound short stature. Congenital hypogonadism occurs in half of patients, and nearly all have documented hypogonadotropic hypogonadism during puberty, with subsequent reproductive dysfunction. Chorioretinal atrophy is typically noted in the first 5 years of life. Half of reported cases have spinocerebellar involvement, including ataxia, spastic paraplegia, and peripheral neuropathy (summary by Hufnagel et al., 2015).Laurence-Moon syndrome (OMIM ) is an allelic disorder with overlapping features.

Genes related to Oliver-mcfarlane Syndrome; Omcs

PNPLA6

View recommended genes panels

Clinical Features

Top most frequent phenotypes and symptoms related to Oliver-mcfarlane Syndrome; Omcs

Intellectual disability
Short stature
Ataxia
Growth delay
Nystagmus
Failure to thrive
Muscle weakness
Cryptorchidism
Cognitive impairment
Peripheral neuropathy

And another 42 symptoms. If you need more information about this disease we can help you.

Click here to know more about Mendelian.

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
— No data available about the known clinical features onset.

Alternative names

Oliver-mcfarlane Syndrome; Omcs Is also known as eyelashes, long, with mental retardation, trichomegaly with mental retardation, dwarfism, and pigmentary degeneration of retina.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Oliver-mcfarlane Syndrome; Omcs Recommended genes panels

Panel Name, Specifity and genes Tested/covered
HSP, Comprehensive Evaluation. By Athena Diagnostics Inc (United States). RTN2, SACS, SPG11, ATL1, SPAST, SPG7, BSCL2, PNPLA6, NIPA1, SPART, SPG21, ZFYVE26, FA2H, AP5Z1, REEP1, CYP7B1, WASHC5, ALS2, HSPD1, KIF5A , (...) View the complete list with 4 more genes Panel complete gene list RTN2, SACS, SPG11, ATL1, SPAST, SPG7, BSCL2, PNPLA6, NIPA1, SPART, SPG21, ZFYVE26, FA2H, AP5Z1, REEP1, CYP7B1, WASHC5, ALS2, HSPD1, KIF5A, L1CAM, KIF1A, PLP1, SLC33A1 Specificity 5 % Genes 100 %
HSP, Supplemental Sporadic Evaluation. By Athena Diagnostics Inc (United States). RTN2, SACS, SPG11, ATL1, BSCL2, PNPLA6, NIPA1, SPART, SPG21, ZFYVE26, FA2H, AP5Z1, REEP1, CYP7B1, WASHC5, ALS2, HSPD1, KIF5A, L1CAM, KIF1A , (...) View the complete list with 2 more genes Panel complete gene list RTN2, SACS, SPG11, ATL1, BSCL2, PNPLA6, NIPA1, SPART, SPG21, ZFYVE26, FA2H, AP5Z1, REEP1, CYP7B1, WASHC5, ALS2, HSPD1, KIF5A, L1CAM, KIF1A, PLP1, SLC33A1 Specificity 5 % Genes 100 %
HSP, Supplemental Recessive Evaluation. By Athena Diagnostics Inc (United States). SACS, PNPLA6, SPART, SPG21, FA2H, AP5Z1, CYP7B1, ALS2, KIF1A Specificity 12 % Genes 100 %
HSP, Complete Recessive Evaluation. By Athena Diagnostics Inc (United States). SACS, SPG11, SPG7, PNPLA6, SPART, SPG21, ZFYVE26, FA2H, AP5Z1, CYP7B1, ALS2, KIF1A Specificity 9 % Genes 100 %
Hereditary Spastic Paraplegia Panel. By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States). RTN2, SACS, SLC16A2, SLC2A1, KDM5C, SPG11, ATL1, SPAST, SPG7, TFG, ACOX1, TREX1, UCHL1, VAMP1, ERLIN2, CAPN1, BSCL2, SAMHD1, PNPLA6, ERLIN1 , (...) View the complete list with 59 more genes Panel complete gene list RTN2, SACS, SLC16A2, SLC2A1, KDM5C, SPG11, ATL1, SPAST, SPG7, TFG, ACOX1, TREX1, UCHL1, VAMP1, ERLIN2, CAPN1, BSCL2, SAMHD1, PNPLA6, ERLIN1, NIPA1, RAB3GAP2, BICD2, GJC2, EXOSC3, REEP2, SPART, CPT1C, IFIH1, GBA2, DDHD1, TECPR2, SPG21, CYP2U1, KLC2, ZFYVE26, TUBB3, TUBB4A, HACE1, FARS2, FA2H, AP5Z1, ADAR, VPS37A, C19orf12, RNASEH2B, PGAP1, REEP1, CYP7B1, ZFYVE27, C12orf65, WDR45, WASHC5, DDHD2, KIDINS220, ATP13A2, ENTPD1, B4GALNT1, ALS2, HSPD1, AP4B1, AP4E1, AP4M1, AP4S1, ABCD1, KIF1C, KIF5A, L1CAM, MAG, MARS, MECP2, NT5C2, OPA3, KIF1A, PLA2G6, PLP1, PQBP1, SLC33A1, ALDH18A1 Specificity 2 % Genes 100 %
Test for Spastic Paraplegia 39. By Genome Diagnostics Laboratory University Medical Center Utrecht (Netherlands). PNPLA6 Specificity 100 % Genes 100 %
HSPAR panel. By Genome Diagnostics Laboratory University Medical Center Utrecht (Netherlands). SACS, SPG11, SPG7, CCT5, PNPLA6, GJC2, SPART, SPG21, ZFYVE26, CYP7B1 Specificity 10 % Genes 100 %
Hereditary Spastic Paraplegia Exome Panel. By Genetic Services Laboratory University of Chicago (United States). RTN2, SACS, SLC16A2, SLC2A1, KDM5C, SPG11, ATL1, SPAST, SPG7, VAMP1, ERLIN2, CAPN1, BSCL2, PNPLA6, ERLIN1, NIPA1, GJC2, EXOSC3, SPART, CPT1C , (...) View the complete list with 36 more genes Panel complete gene list RTN2, SACS, SLC16A2, SLC2A1, KDM5C, SPG11, ATL1, SPAST, SPG7, VAMP1, ERLIN2, CAPN1, BSCL2, PNPLA6, ERLIN1, NIPA1, GJC2, EXOSC3, SPART, CPT1C, GBA2, DDHD1, TECPR2, SPG21, ZFYVE26, FARS2, FA2H, AP5Z1, C19orf12, REEP1, CYP7B1, C12orf65, IBA57, WASHC5, DDHD2, KIDINS220, ATP13A2, ENTPD1, B4GALNT1, ALS2, HSPD1, AP4B1, AP4E1, AP4M1, AP4S1, ABCD1, KIF1C, KIF5A, L1CAM, MAG, ARL6IP1, NT5C2, KIF1A, PLP1, SLC33A1, ALDH18A1 Specificity 2 % Genes 100 %

You can get up to 39 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

OMIM Rare Disease Search Engine

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like THROMBOCYTOPENIA WITH CONGENITAL DYSERYTHROPOIETIC ANEMIA NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1B; LGMD1B CHIARI MALFORMATION TYPE II